These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6139932)

  • 1. Effect on brain monoamines in the rat of substituted and protected analogues of the oxytocin fragment, prolyl-leucyl-glycinamide following N-terminal substitution by homoproline.
    Szabó G; Kovács GL; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1983; 62(1):25-33. PubMed ID: 6139932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on brain monoamines in the rat of substituted and protected analogues of the oxytocin fragment, prolyl-leucyl-glycinamide following N-terminal substitution by D- and L-pipecolic acid.
    Szabó G; Kovács GL; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1986; 67(1):155-61. PubMed ID: 2871693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.
    Pugsley TA; Lippmann W
    Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Pro-Leu-Gly-NH2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN.
    Johnson RL; Rajakumar G; Yu KL; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2104-7. PubMed ID: 2876104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
    Sheng JG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiamnesic effects of D-pipecolic acid and analogues of Pro-Leu-Gly-NH2 in rats.
    Kovács GL; Szabó G; Telegdy G; Baláspiri L; Pálos E; Szpornyi L
    Pharmacol Biochem Behav; 1988 Dec; 31(4):833-7. PubMed ID: 2908068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular administration of vasopressin and oxytocin effects the steady-state levels of serotonin, dopamine and norepinephrine in rat brain.
    Schwarzberg H; Kovács GL; Szabó G; Telegdy G
    Endocrinol Exp; 1981; 15(2):75-80. PubMed ID: 6973462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
    Ott MC; Mishra RK; Johnson RL
    Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Baures PW; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2349-52. PubMed ID: 10476867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives.
    Rajakumar G; Singh AN; Naas F; Chiu S; Kwan CY; Johnson RL; Mishra RK
    J Hypertens Suppl; 1986 Dec; 4(5):S106-8. PubMed ID: 2883271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of histamine H1- and H2-receptor antagonists on dopamine, noradrenaline and serotonin systems in rat brain.
    Nowak JZ
    Pol J Pharmacol Pharm; 1980; 32(4):451-61. PubMed ID: 6114483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-Leu-GlyNH2 affects dopamine and noradrenaline utilization in rat limbic-forebrain nuclei.
    van Heuven-Nolsen D; de Kloet ER; Versteeg DH
    Brain Res; 1984 Nov; 322(2):213-8. PubMed ID: 6150749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.
    Yoshitake T; Kehr J; Yoshitake S; Fujino K; Nohta H; Yamaguchi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):177-83. PubMed ID: 15203027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during aging.
    Míguez JM; Aldegunde M; Paz-Valiñas L; Recio J; Sánchez-Barceló E
    J Neural Transm (Vienna); 1999; 106(11-12):1089-98. PubMed ID: 10651105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.
    Gorzalka BB; Luck KA; Tanco SA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholecystokinin antiserum on the brain monoamine content in rats.
    Fekete M; Kádár T; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(2):177-83. PubMed ID: 7315376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogues possessing cyclic amino acid residues at the C-terminal position.
    Johnson RL; Rajakumar G; Mishra RK
    J Med Chem; 1986 Oct; 29(10):2100-4. PubMed ID: 2876103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.
    Dolbeare K; Pontoriero GF; Gupta SK; Mishra RK; Johnson RL
    J Med Chem; 2003 Feb; 46(5):727-33. PubMed ID: 12593653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the pharmacological effects of L-prolyl-L-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?
    Chiu S; Wong YW; Wan YP; Chiu P; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):739-42. PubMed ID: 6141616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VD; Konstantinova E
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.